CAR-T (Shanghai) Biotechnology Co., Ltd.
5 clinical trials · Sponsor
◉ Watch CAR-T (Shanghai) Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression (NCT05127369) | CAR-T (Shanghai) Biotechnology Co., Ltd. | 2022-01-01 |
| Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells (NCT04302519) | CAR-T (Shanghai) Biotechnology Co., Ltd. | 2020-03-05 |
| Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis (NCT04130100) | CAR-T (Shanghai) Biotechnology Co., Ltd. | 2019-04-04 |
| Stem Cells From Human Exfoliated Teeth in Treatment of Diabetic Patients With Significantly Reduced Islet Function (NCT03912480) | CAR-T (Shanghai) Biotechnology Co., Ltd. | 2019-01-05 |
| Stem Cells From Human Exfoliated Teeth in Treatment of Type 2 Diabetes (NCT03658655) | CAR-T (Shanghai) Biotechnology Co., Ltd. | 2018-06-01 |
Track CAR-T (Shanghai) Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.